Status:
UNKNOWN
RSA for a Comparison of MIS vs. Standard Exposure in Total Hip Arthroplasty
Lead Sponsor:
Dalhousie University
Collaborating Sponsors:
Stryker Trauma and Extremities
Conditions:
Osteoarthritis
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if MIS for primary hip replacement surgery increases the risk of long term aseptic loosening as predicted by implant micromotion detected by radiostereometric...
Detailed Description
Hip replacement is an effective option for treating chronic hip conditions that cause pain and functional impairment(1). Significant improvements in quality of life, as measured by both disease specif...
Eligibility Criteria
Inclusion
- Subjects are under the age of 65 years
- Subjects have not had hip replacement surgery on the affected hip
- Subjects have decided to undergo a primary total hip replacement of the affected hip
Exclusion
- Having a previous hip infection
- Undergoing surgery for arthritis due to a previous injury, rheumatoid arthritis or hip dysplasia (a hip that did not develop completely)
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00405483
Start Date
October 1 2005
End Date
December 1 2019
Last Update
February 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 3A7